McClellan Reinforces FDA Advertising Surveillance, Warning Letter Policy
This article was originally published in The Gray Sheet
Executive Summary
FDA remains committed to its vigilant oversight of direct-to-consumer advertising following a request for expedited handling of DTC ad warning letters by the General Accounting Office